PAWANA ITANI: Open Payments
NPI 1174303929 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 32 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $169 |
| Lilly USA, LLC | 10 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Astellas Pharma US Inc | 3 | $48 |
| ABBVIE INC. | 2 | $30 |
| Exact Sciences Corporation | 2 | $29 |
| Sage Therapeutics, LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: FARXIGA, JARDIANCE, MOUNJARO, Veozah, VRAYLAR, ZURZUVAE, LEQVIO, GEMTESA.
Industry payments across OK — which companies pay providers there.
